Managing Gout in Women: Current Perspectives

Area of Science:

• Rheumatology
• Clinical Pharmacology
• Women's Health

Background:

• Gout disproportionately affects men, but women experience higher disease burden and more comorbidities like hypertension, diabetes, and renal dysfunction.
• Existing gout pharmacotherapies' efficacy in women compared to men remains a critical question due to observed sex discrepancies in disease impact.

Purpose of the Study:

• To compare the clinical profiles of male and female gout patients.
• To review the literature on the efficacy of urate-lowering therapies and acute flare treatments in women with gout.
• To discuss specific management considerations for gout in women, particularly during pregnancy and lactation.

Main Methods:

• Literature review of studies comparing gout patient profiles.
• Survey of clinical trial data and observational studies on gout pharmacotherapy outcomes in females.
• Synthesis of current evidence regarding gout management in pregnant and lactating women.

Main Results:

• Female gout patients present with distinct clinical profiles and comorbidities compared to males.
• Data on the comparative efficacy of gout pharmacotherapies in women versus men is limited and warrants further investigation.
• Specific considerations are necessary for managing gout in women, especially concerning reproductive status.

Conclusions:

• The greater disease burden and comorbidity profile in women necessitate a closer examination of gout treatment efficacy and safety.
• Further research is crucial to optimize gout management strategies for female patients, addressing potential sex-based differences in treatment response.
• Specialized approaches are required for managing gout in women during pregnancy and lactation to ensure maternal and fetal well-being.